While generic versions won't appear immediately, more affordable options are expected in 2026
Patients were diverse regarding race/ethnicity (36% non-Hispanic White, 36% Hispanic, 27% Black) and cirrhosis etiology (50% hepatitis C virus, 25% nonalcoholic steatohepatitis, 20% alcohol)
Cho HS, Lee MH, Lee JW, No KO, Park SK, eta al
This is different from a compounded formula, which is not FDA approved and where little research currently exists surrounding safety and efficacy.53 Patients using compounded versions may not receive a standardized dose, and safety and efficacy data for these products is currently lacking
GLP-1RAs have been correlated with a decreased risk of hepatic decompensation and liver cancer, with this protective effect being more significant in patients who do not have alcohol or tobacco use disorders as compared to those who do [42]